Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-700
Closed -$192K 401
2018
Q1
$192K Sell
700
-100
-13% -$31K 0.02% 298
2017
Q4
$255K Buy
800
+100
+14% +$32.1K 0.03% 279
2017
Q3
$219K Sell
700
-2,800
-80% -$829K 0.04% 197
2017
Q2
$950K Buy
+3,500
New +$925K 0.14% 131
2016
Q4
Sell
-1,000
Closed -$313K 165
2016
Q3
$313K Sell
1,000
-2,700
-73% -$800K 0.04% 120
2016
Q2
$895K Buy
3,700
+3,672
+13,114% +$968K 0.04% 285
2016
Q1
$729K Sell
28
-14
-33% -$3.7K 0.03% 262
2015
Q4
$1.29M Sell
42
-61
-59% -$17.5K 0.04% 212
2015
Q3
$2.61M Sell
103
-6,497
-98% -$2.15M 0.03% 88
2015
Q2
$2.67M Buy
6,600
+3,000
+83% +$1.2M 0.05% 128
2015
Q1
$1.52M Buy
3,600
+1,200
+50% +$473K 0.05% 173
2014
Q4
$816K Buy
2,400
+1,000
+71% +$324K 0.02% 354
2014
Q3
$463K Buy
+1,400
New +$462K 0.01% 418

Other funds holding BIIB

Jump Trading's BIIB Position: Q2 2018 in Review

Jump Trading sold out of Biogen (BIIB) in Q2 2018, closing a stake of 1,564 shares — an estimated $428K sold.

Jump Trading first reported a position in BIIB in Q3 2014 and held it in 11 quarters. The position peaked at $1.05M in Q1 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Jump Trading reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Jump Trading sold 1,564 Biogen shares in Q2 2018, an estimated $428K.
  • Jump Trading first reported a position in Biogen in Q3 2014 and held it in 11 quarters.
  • Jump Trading's Biogen position peaked at $1.05M in Q1 2015.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Jump Trading's 13F filing for Q2 2018, filed 14 Aug 2018.